Announcements Trials
Browse Landscape

Phase

Phase 1 2Phase 3 1Phase 2 1

Status

Active not recruiting 6Recruiting 4Completed 2Approved for marketing 1

Sponsor Class

INDUSTRY 3OTHER 1

Study Type

Interventional 4

Sponsor

Cancer Type

Thoracic 4

Conditions

Small Cell Lung Carcinoma 3Extensive Stage Small Cell Lung Cancer 1

Interventions

pembrolizumab 567Specimen Handling 487Carboplatin 456Magnetic Resonance Spectroscopy 442Cyclophosphamide 418Cisplatin 412Radiotherapy 353Gemcitabine 318Bevacizumab 317Paclitaxel 304Biopsy 291Drug Therapy 286Blood Specimen Collection 249Capecitabine 244Oxaliplatin 242fludarabine 238Nivolumab 236venetoclax 227Injections 214Docetaxel 209Fluorouracil 204Dexamethasone 187Radiosurgery 182Rituximab 162Pemetrexed 160Standard of Care 156Surgical Procedures, Operative 148durvalumab 146atezolizumab 146tislelizumab 140

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Recruiting × AMG 757 × Clear all
NCT07005128 2026-05-22

DeLLphi-312

Amgen

Phase 3 Recruiting
330 enrolled
Thoracic

Small Cell Lung Carcinoma

NCT07037758 2026-03-27

DeLLphi-311

Amgen

Phase 1 Recruiting
380 enrolled
Thoracic

Extensive Stage Small Cell Lung Cancer

NCT07423585 2026-02-20

Tarlatamab for the Treatment of Extensive Stage Small-cell Lung Cancer

Ohio State University Comprehensive Cancer Center

Phase 2 Recruiting
39 enrolled
Thoracic

Small Cell Lung Carcinoma

NCT06598306 2025-12-01

DeLLphi-308

Amgen

Phase 1 Recruiting
220 enrolled
Thoracic

Small Cell Lung Carcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡